• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP Back to Search Results
Catalog Number PAJR060502B
Device Problem Complete Blockage (1094)
Patient Problem Stenosis (2263)
Event Date 05/17/2019
Event Type  Injury  
Manufacturer Narrative
Additional reports submitted: 2017233-2020-00186, 2017233-2020-00185.The date the article was accepted is being used as the date of event.
 
Event Description
The following information was reported to gore: in an article titled technical considerations and clinical outcomes in the endovascular management of celiac arterial aneurysms it states some patients who underwent treatment of celiac artery aneurysms who were treated with either gore® viabahn® endoprosthesis with propaten bioactive surface or gore® viabahn® vbx balloon expandable endoprosthesis had device related post-procedural complications: patient no.4 was treated with an atrium and a gore® viabahn® endoprosthesis with propaten bioactive surface.This patient exhibited rebleeding angiomyolipoma and 80% in-stent restenosis sir grade c.
 
Event Description
The following information was reported to gore: in an article titled technical considerations and clinical outcomes in the endovascular management of celiac arterial aneurysms it states some patients who underwent treatment of celiac artery aneurysms who were treated with either gore® viabahn® endoprosthesis with propaten bioactive surface or gore® viabahn® vbx balloon expandable endoprosthesis had device related post-procedural complications: patient no.4 was treated with an atrium and a gore® viabahn® endoprosthesis with propaten bioactive surface.This patient exhibited rebleeding angiomyolipoma and 80% in-stent restenosis sir grade c.Complete stent graft thrombosis with good collateral flow through the gda into the pha was demonstrated on follow-up ct angiogram imaging in patient #4, despite prior angioplasty of the stenosed segment with a drug-coated balloon.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9957525
MDR Text Key194035810
Report Number2017233-2020-00249
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial,Followup
Report Date 04/15/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberPAJR060502B
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/14/2020
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received04/15/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age55 YR
-
-